This Week’s Biotech Highlights

Swine Flu, of course, dominated the weekend’s news. I have collected some info on reliable statistics, resources and updates, and have added a Google News RSS and a Twitter RSS to the front page of the Cross-Border Biotech Blog

My own personal (non-medical) mini-faq:

  1. coughing and fever seem to be diagnostic differentiators — if you don’t have those symptoms, you probably don’t have flu. Check WebMD if you want. Their guys have been asking a zillion symptoms questions on the CDC update calls; and
  2. you can not get swine flu from eating pork, just from the guy who makes your pulled-pork sandwich, so cover your mouths when you cough and wash your hands a lot.

Overall, the response seems quite proactive and will probably work as intended.

Other things this week that worked as intended:

That, plus news of Canada’s first Subsequent Entry Biologic and a Wednesday Brain Dump about plants and crop science wraps up this week in biotech.

Finally, hope to see you at BioFinance this week, where I’ll be speaking on the Public Market Strategies for Cleantech Investing panel on Thursday, April 30 at 3pm. Admission to the Cleantech day of BioFinance is free, and the whole conference is excellent, so come check it out at the Toronto Marriott Eaton Centre.

Retweet information »

Comments are closed.